These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 3793172

  • 1. Reaction of 2-nitroimidazole metabolites with guanine and possible biological consequences.
    Whitmore GF, Varghese AJ, Gulyas S.
    IARC Sci Publ; 1986; (70):185-96. PubMed ID: 3793172
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Modification of the action of misonidazole. I. Effect of TAN on toxicity.
    Skov KA, Palcic B, Harrison IE, Skarsgard LD.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Jun; 37(6):601-11. PubMed ID: 6968295
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Detection of a reactive metabolite of misonidazole in hypoxic mammalian cells.
    Varghese AJ, Whitmore GF.
    Radiat Res; 1984 Feb; 97(2):262-71. PubMed ID: 6538047
    [Abstract] [Full Text] [Related]

  • 6. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole.
    Varghese AJ, Whitmore GF.
    Cancer Res; 1980 Jul; 40(7):2165-9. PubMed ID: 6155991
    [Abstract] [Full Text] [Related]

  • 7. Comparative DNA damage induced by nitroimidazole-aziridine drugs: 1. Effects of methyl substitution on drug action.
    Dale LD, Tocher JH, Edwards DI.
    Anticancer Drug Des; 1988 Dec; 3(3):169-75. PubMed ID: 3207464
    [Abstract] [Full Text] [Related]

  • 8. Influence of heat on the intracellular uptake and radiosensitization of 2-nitroimidazole hypoxic cell sensitizers in vitro.
    Brown DM, Cohen MS, Sagerman RH, Gonzalez-Mendez R, Hahn GM, Brown JM.
    Cancer Res; 1983 Jul; 43(7):3138-42. PubMed ID: 6850622
    [Abstract] [Full Text] [Related]

  • 9. Stable reduction product of misonidazole.
    Panicucci R, McClelland RA, Rauth AM.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1227-30. PubMed ID: 3744942
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Action of misonidazole on L5178Y-R and L5178Y-S cells. II. Cytotoxicity and radiosensitization under hypoxic conditions.
    Niepokojczycka E, Szumiel I, Walicka M.
    Neoplasma; 1981 Jul; 28(4):435-40. PubMed ID: 7290267
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Toxic and radiosensitizing effect of reduced nitroimidazoles on E. coli B/r cells].
    Riabchenko NI, Semin IuA, Petrova KM, Kutmin AI.
    Radiobiologiia; 1983 Jul; 23(4):505-9. PubMed ID: 6351162
    [Abstract] [Full Text] [Related]

  • 18. Reactions of nucleosides with glyoxal and acrolein.
    Shapiro R, Sodum RS, Everett DW, Kundu SK.
    IARC Sci Publ; 1986 Jul; (70):165-73. PubMed ID: 3793171
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
    Papadopoulou MV, Ji M, Khan SH, Bloomer WD.
    Oncol Res; 1999 Jul; 11(8):345-57. PubMed ID: 10803738
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.